echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Crit Care: Evaluation of the effect of zinc sulfate as an adjuvant treatment for critically ill patients with COVID-19

    Crit Care: Evaluation of the effect of zinc sulfate as an adjuvant treatment for critically ill patients with COVID-19

    • Last Update: 2021-11-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Zinc is a trace element that plays an important role in stimulating innate and acquired immunity
    .


    The role of zinc in critically ill patients with COVID-19 is not yet clear


    Immune to COVID-19

    Recently, a research article published in Critical Care, an authoritative journal in the field of critical care medicine, aims to evaluate the effectiveness and safety of zinc sulfate as an adjuvant treatment for critically ill patients with COVID-19
    .

    Researchers conducted a retrospective evaluation of zinc use in patients with COVID-19 who were admitted to the intensive care unit (ICU) in two tertiary hospitals in Saudi Arabia from March 1, 2020 to March 31, 2021 and were aged ≥18 years.

    .


    After matching propensity scores based on selected criteria (1:1 ratio), the researchers assessed the association between zinc used as an adjuvant treatment and 30-day mortality


    A total of 164 patients were enrolled in the study, and 82 patients were treated with zinc
    .


    Patients who received zinc sulfate as adjuvant therapy had a lower 30-day mortality rate (HR 0.


    It can be seen that the use of zinc sulfate as a supplementary treatment for critically ill patients with COVID-19 may improve survival
    .


    In addition, zinc supplementation may have a protective effect on the kidneys


    Using zinc sulfate as a supplementary treatment for critically ill patients with COVID-19 may improve survival


    Original source:

    Khalid Al Sulaiman.


    Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.